Tineta Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 1.93 Cr
as on 22-06-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.55 Cr
as on 22-06-2024
- Revenue 28.79%
(FY 2022)
- Profit 244.55%
(FY 2022)
- Ebitda 365.92%
(FY 2022)
- Net Worth 97.68%
(FY 2022)
- Total Assets 21.55%
(FY 2022)
About Tineta Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.93 Cr.
The company has closed loans amounting to ₹2.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pradeep Verma, Subodh Menon, Perumangode Ramaswamy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC088871
- Company No.
088871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tineta Pharma Private Limited offer?
Tineta Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Tineta Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Verma  | Director | 29-May-1995 | Current |
| Subodh Menon | Additional Director | 27-Feb-2024 | Current |
| Perumangode Ramaswamy | Additional Director | 27-Feb-2024 | Current |
| Sudhir Menon | Additional Director | 27-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Tineta Pharma.
Tineta Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.79% increase. The company also saw a substantial improvement in profitability, with a 244.55% increase in profit. The company's net worth Soared by an impressive increase of 97.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tineta Pharma?
In 2023, Tineta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rfly Innovations Private LimitedActive 7 years 1 monthSubodh Menon and Sudhir Menon are mutual person
- Khyati Speciality Chemicals Private LimitedActive 4 years 3 months
Subodh Menon and Sudhir Menon are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Oct 2011 | ₹1.00 Cr | Satisfied |
The Greater Bombay Co-Op Bank Ltd Creation Date: 30 Jan 2006 | ₹1.55 Cr | Satisfied |
How Many Employees Work at Tineta Pharma?
Tineta Pharma has a workforce of 308 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tineta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tineta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
